The FDA has announced updated warnings for liquid-filled intragastric balloons, medical devices used to treat obesity, after five deaths following balloon implants. All of the victims were implanted with devices from either Apollo Endosurgery or ReShape Medical. The updated warning comes nearly six months after the FDA issued an alert to physicians for certain adverse reactions in patients implanted with Apollo or ReShape devices. The warning acts as a sign of continued device monitoring in the weightless industry. Read the full warning here.
